JNJ Stock Dips 0.29% on Orthopedics Unit Reports and Rate Concerns

Johnson & Johnson's stock closed at $265.58 on the New York Stock Exchange (NYSE) on September 11, 2026, down 0.29 percent for the session.

The decline came as investors weighed reports of a potential sale of its orthopedics unit and broader market rate concerns.

However, in after-hours trading, the stock showed an uptick to $265.99.

Johnson & Johnson's shares have been near their 12-month high, with recent filings noting that JNJ opened Friday's session at about $265.91.

The company's annual dividend is $5.36 per share, translating into a dividend yield of about 2.02 percent at the September 11, 2026 closing price.